ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Introduction Pulmonary embolism (PE) and deep vein thrombosis (DVT), the two clinical
manifestations of venous thromboembolism (VTE), constitute a major global burden of …

Compared with nonpregnant women, pregnancy carries a four-to fivefold higher risk of
venous thromboembolism (VTE). Despite increasing use of heparin prophylaxis in identified …

Objective To compare two different treatment durations of rivaroxaban in patients with
symptomatic isolated distal deep vein thrombosis (DVT). Design Randomised, double blind …

Purpose To systematically assess test performance of patient‐adapted D‐dimer cut‐offs for
the diagnosis of venous thromboembolism (VTE). Methods Systematic review and analysis …

Importance As venous thromboembolism (VTE) remains one of the leading causes of
maternal mortality, identifying women at increased risk of VTE is of great importance …

Occlusions in the blood vessels caused by blood clots, referred to as thrombosis, and the
subsequent outcomes are leading causes of morbidity and mortality worldwide. In vitro and …

The prevalence of intravenous drug use has increased in the past decade and it represents
an important risk factor for deep vein thrombosis. Intravenous drug use is a global problem …

Background: Pulmonary thromboembolism is a common disease frequently encountered in
the emergency room and has a high mortality rate. Antiphospholipid syndrome (APS) is a …

Unprovoked Venous Thromboembolism - Medical Clinics Skip to Main Content
Advertisement Medical Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com …